RABEPRAZOLE
RABEPRAZOLE
Approved
DIN Number
02385449
Drug Class
Human
Market Date
Jun 10, 2012
Company
HC
sivem pharmaceuticals ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02385449
AIG Number0143681001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC04 RABEPRAZOLE
Product Specifications
Dosage FormTablet (Enteric-Coated)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification
ACTIVE INGREDIENTS (1)
RABEPRAZOLE SODIUMActive
Strength: 10 MG
Monograph: RABEPRAZOLE SODIUM